Source Financial Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
$648K Buy
731
+12
+2% +$10.8K 0.19% 59
2024
Q2
$651K Sell
719
-29
-4% -$23.2K 0.2% 56
2024
Q1
$582K Buy
748
+43
+6% +$30.6K 0.18% 65
2023
Q4
$411K Sell
705
-4
-0.6% -$2.33K 0.13% 87
2023
Q3
$381K Buy
709
+3
+0.4% +$1.55K 0.13% 87
2023
Q2
$331K Buy
+706
New +$296K 0.11% 103
2023
Q1
Sell
-751
Closed -$275K 127
2022
Q4
$275K Buy
751
+43
+6% +$15.2K 0.1% 108
2022
Q3
$229K Buy
708
+54
+8% +$17.1K 0.09% 103
2022
Q2
$212K Buy
+654
New +$196K 0.08% 107

Other funds holding LLY

Source Financial Advisors's LLY Position: Q3 2024 in Review

Source Financial Advisors increased its Eli Lilly (LLY) stake by 1.7% in Q3 2024, buying an estimated $10.8K and bringing the position to 731 shares worth $648K. The position accounts for 0.19% of the portfolio, ranked #59.

Source Financial Advisors first reported a position in LLY in Q2 2022 and has held it in 9 quarters since. The position peaked at $651K in Q2 2024. 3,657 funds tracked by Wall St. Rank hold LLY as of Q3 2024.

  • Source Financial Advisors held 731 shares of Eli Lilly worth $648K as of Q3 2024.
  • Source Financial Advisors bought 12 Eli Lilly shares in Q3 2024, an estimated $10.8K.
  • Eli Lilly made up 0.19% of Source Financial Advisors's portfolio in Q3 2024, its #59 holding.
  • Source Financial Advisors first reported a position in Eli Lilly in Q2 2022 and has held it in 9 quarters since.
  • Source Financial Advisors's Eli Lilly position peaked at $651K in Q2 2024.
  • 3,657 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2024.

Based on Source Financial Advisors's 13F filing for Q3 2024, filed 1 Nov 2024.